After long negotiations, an agreement was reached by the Swiss Nestle and American Pfizer. Сделка о приобретении подразделения Pfizer — Pfizer Nutrition has taken place and is now awaiting regulatory approval.
Nestlé Corporation is the world market leader in baby food products, its competitors Mead Johnson и Danone also made a joint offer to Pfizer, but they failed to exceed the price of Nestlé. The deal will cost the Swiss corporation $11.85 billion. Over the past 10 years, this agreement has become the largest in the history of Nestlé.
For Nestlé, the deal is an excellent opportunity to strengthen its position as a leader, as well as increase its presence in the emerging markets. Pfizer, in its second non-pharmaceutical sale, is sticking to its restructuring strategy and focusing on its core business.
